Suppr超能文献

手术切除范围及淋巴结评估在临床Ⅰ期肺鳞屑样腺癌中的作用:1991例患者分析

The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

作者信息

Cox Morgan L, Yang Chi-Fu Jeffrey, Speicher Paul J, Anderson Kevin L, Fitch Zachary W, Gu Lin, Davis Robert Patrick, Wang Xiaofei, D'Amico Thomas A, Hartwig Matthew G, Harpole David H, Berry Mark F

机构信息

Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina.

出版信息

J Thorac Oncol. 2017 Apr;12(4):689-696. doi: 10.1016/j.jtho.2017.01.003. Epub 2017 Jan 8.

Abstract

BACKGROUND

This study examined the association of extent of lung resection, pathologic nodal evaluation, and survival for patients with clinical stage I (cT1-2N0M0) adenocarcinoma with lepidic histologic features in the National Cancer Data Base.

METHODS

The association between extent of surgical resection and long-term survival for patients in the National Cancer Data Base with clinical stage I lepidic adenocarcinoma who underwent lobectomy or sublobar resection was evaluated using Kaplan-Meier and Cox proportional hazards regression analyses.

RESULTS

Of the 1991 patients with cT1-2N0M0 lepidic adenocarcinoma who met the study criteria, 1544 underwent lobectomy and 447 underwent sublobar resection. Patients treated with sublobar resection were older, more likely to be female, and had higher Charlson/Deyo comorbidity scores, but they had smaller tumors and lower T status. Of the patients treated with lobectomy, 6% (n = 92) were upstaged because of positive nodal disease, with a median of seven lymph nodes sampled (interquartile range 4-10). In an analysis of the entire cohort, lobectomy was associated with a significant survival advantage over sublobar resection in univariate analysis (median survival 9.2 versus 7.5 years, p = 0.022, 5-year survival 70.5% versus 67.8%) and after multivariable adjustment (hazard ratio = 0.81, 95% confidence interval: 0.68-0.95, p = 0.011). However, lobectomy was no longer independently associated with improved survival when compared with sublobar resection (hazard ratio = 0.99, 95% confidence interval: 0.77-1.27, p = 0.905) in a multivariable analysis of a subset of patients in which only those patients who had undergone a sublobar resection including lymph node sampling were compared with patients treated with lobectomy.

CONCLUSIONS

Surgeons treating patients with stage I lung adenocarcinoma with lepidic features should cautiously utilize sublobar resection rather than lobectomy, and they must always perform adequate pathologic lymph node evaluation.

摘要

背景

本研究在国家癌症数据库中,调查了临床I期(cT1-2N0M0)具有鳞屑状组织学特征的腺癌患者的肺切除范围、病理淋巴结评估与生存之间的关联。

方法

使用Kaplan-Meier法和Cox比例风险回归分析,评估国家癌症数据库中接受肺叶切除术或肺段以下切除术的临床I期鳞屑状腺癌患者的手术切除范围与长期生存之间的关联。

结果

在1991例符合研究标准的cT1-2N0M0鳞屑状腺癌患者中,1544例行肺叶切除术,447例行肺段以下切除术。接受肺段以下切除术的患者年龄更大,更可能为女性,Charlson/Deyo合并症评分更高,但肿瘤更小,T分期更低。在接受肺叶切除术的患者中,6%(n = 92)因淋巴结疾病阳性而分期上调,中位取样淋巴结数为7个(四分位间距4-10)。在对整个队列的分析中,在单因素分析中肺叶切除术与肺段以下切除术相比具有显著的生存优势(中位生存期9.2年对7.5年,p = 0.022,5年生存率70.5%对67.8%),且在多变量调整后(风险比=0.81,95%置信区间:0.68-0.95,p = 0.011)。然而,在仅将接受包括淋巴结取样的肺段以下切除术的患者与接受肺叶切除术的患者进行比较的亚组患者的多变量分析中,与肺段以下切除术相比,肺叶切除术不再与生存改善独立相关(风险比=0.99,95%置信区间:0.77-1.27,p = 0.905)。

结论

治疗具有鳞屑状特征的I期肺腺癌患者的外科医生应谨慎采用肺段以下切除术而非肺叶切除术,并且必须始终进行充分的病理淋巴结评估。

相似文献

2
Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
Clin Lung Cancer. 2016 Jan;17(1):47-55. doi: 10.1016/j.cllc.2015.07.005. Epub 2015 Aug 3.
3
Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
Ann Thorac Surg. 2014 May;97(5):1701-7. doi: 10.1016/j.athoracsur.2014.02.024. Epub 2014 Mar 26.
4
Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
Ann Thorac Surg. 2018 Aug;106(2):375-381. doi: 10.1016/j.athoracsur.2018.02.049. Epub 2018 Mar 23.
5
Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
J Thorac Cardiovasc Surg. 2018 Jul;156(1):394-402. doi: 10.1016/j.jtcvs.2018.03.113. Epub 2018 Apr 4.
6
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
J Thorac Cardiovasc Surg. 2014 Feb;147(2):754-62; Discussion 762-4. doi: 10.1016/j.jtcvs.2013.09.065. Epub 2013 Nov 23.
7
Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
J Cancer Res Clin Oncol. 2017 Nov;143(11):2375-2382. doi: 10.1007/s00432-017-2499-y. Epub 2017 Aug 17.
8
Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors.
Ann Thorac Surg. 2018 Jan;105(1):207-213. doi: 10.1016/j.athoracsur.2017.07.049. Epub 2017 Nov 11.
9
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
Ann Thorac Surg. 2006 Aug;82(2):408-15; discussion 415-6. doi: 10.1016/j.athoracsur.2006.02.029.
10
Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
Ann Surg Oncol. 2020 Mar;27(3):703-715. doi: 10.1245/s10434-019-07974-9. Epub 2019 Oct 23.

引用本文的文献

1
Development and Validation of Predictive Models for Differentiating Resectable Stage III Peripheral SCLC from NSCLC Using Radiomic Features and Clinical Parameters.
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251368956. doi: 10.1177/15330338251368956. Epub 2025 Aug 21.
3
Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma.
World J Surg Oncol. 2025 Jan 22;23(1):16. doi: 10.1186/s12957-025-03680-x.
6
Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer.
Cancers (Basel). 2023 May 25;15(11):2914. doi: 10.3390/cancers15112914.
7
[Advances in the Study of Invasive Non-mucinous Adenocarcinoma 
with Different Pathological Subtypes].
Zhongguo Fei Ai Za Zhi. 2023 Jan 20;26(1):22-30. doi: 10.3779/j.issn.1009-3419.2022.102.51.
9
Editorial: Strategies of Lymph Node Dissection During Sublobar Resection for Early Stage Lung Cancer.
Front Surg. 2022 Apr 26;9:895806. doi: 10.3389/fsurg.2022.895806. eCollection 2022.

本文引用的文献

2
Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1318-23. doi: 10.1245/s10434-015-4780-0. Epub 2015 Jul 31.
3
Non-Small Cell Lung Cancer, Version 6.2015.
J Natl Compr Canc Netw. 2015 May;13(5):515-24. doi: 10.6004/jnccn.2015.0071.
4
Sublobar resection for early-stage lung cancer.
Transl Lung Cancer Res. 2014 Jun;3(3):164-72. doi: 10.3978/j.issn.2218-6751.2014.06.11.
7
Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management.
AJR Am J Roentgenol. 2014 Mar;202(3):W224-33. doi: 10.2214/AJR.13.11819.
10
Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients.
Ann Thorac Surg. 2013 Nov;96(5):1747-54; discussion 1754-5. doi: 10.1016/j.athoracsur.2013.05.104. Epub 2013 Aug 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验